IP Library Granted Patent US 8,084,588
Granted Patent B2
US 8,084,588 · App. 12/252,721 · Granted Dec 27, 2011

Fluorescence quenching azo dyes, their methods of preparation and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,084,588
App. No.
12/252,721
Granted
Dec 27, 2011
Kind
B2
Abstract

Disclosed is a group of azo quencher compositions useful as fluorescence quenchers having the general structure of formula 1, methods of making or using the compositions, and kits comprising the composition.

Claims (18)

1. A composition, comprising:

a compound for quenching emission of light of the structure of Formula 1:

wherein R 1-6 on the conjugated ring system are individually an electron withdrawing group, alkyl group, aryl group, hydrogen, heteroaryl group, or a five or six member ring structure formed from the R 1 , R 2 pair, the R 3 , R 4 pair, the R 4 , R 5 pair, or the R 5 , R 6 pair; and wherein R 7 is an unsubstituted or substituted aryl or heteroaryl group, the aryl or heteroaryl group being selected from the group consisting of phenyl, xylyl, tolyl, pyridyl, and anilyl groups, with the proviso that the aryl group is not an unsubstituted phenyl or tolyl, and wherein the anilyl group is a group of Formula 2:

wherein L and L′ are the same or different and are a C 1-10 group, —C 1-10 —O—R 8 , or —C 1-10 —O—R 9 ,

wherein C 1-10 is a C 1-10 alkyl group, and wherein R 8 and R 9 are independently a hydrogen, trityl, alkoxytrityl, silyl, cyanoethylphosphoramidite, or phosphoramidite with the proviso that L and L′ are not both methyl, and when L or L′ is ethyl, then the other is not hydroxyethyl; and

a substance linked to the compound of Formula 1 selected from the group consisting of an antigen, a steroid, a vitamin, a drug, a hapten, a metabolite, a toxin, an environmental pollutant, an amino acid, a protein, a nucleoside or nucleotide, an oligonucleotide, a nucleic acid polymer, a carbohydrate, a solid support, or a lipid.

2. The composition of claim 1 wherein the substance linked to the compound of Formula 1 further comprises a fluorophore.

3. The composition of claim 1 wherein either R 8 or R 9 is a phosphoramidite group.

4. The composition of claim 1 wherein the substance is an oligonucleotide.

5. The composition of claim 4 wherein the compound of Formula 1 is linked to the 3′-terminus of the oligonucleotide.

6. The composition of claim 4 wherein the compound of Formula 1 is linked to the 5′-terminus of the oligonucleotide.

7. The composition of claim 1 wherein the substance is a solid support.

8. The composition of claim 7 wherein the solid support is capable of supporting oligonucleotide synthesis.

9. The composition of claim 7 wherein the solid support is controlled pore glass.

10. The composition of claim 1 , wherein the compound of formula 1 is the compound of Formula 13,

wherein CEP is cyanoethylphosphoramidite, and C 1-10 is a C 1-10 alkyl group.

11. The composition of claim 1 , wherein the compound of Formula 1 is the compound of Formula 14,

wherein CEP is cyanoethylphosphoramidite, and C 1-10 is a C 1-10 alkyl group.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Oct 5, 2017
From: JPMORGAN CHASE BANK, N.A.
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 043800/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: LAIKHTER, ANDREI; BEHLKE, MARK AARON; WALDER, JOSEPH; ROBERTS, KEVIN WILLIAM; YONG, YAWFUI
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 029611/0918 →